Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1385/mb:32:3:227.

Title:
Control of the G2/M transition | Molecular Biotechnology
Description:
The G2 checkpoint prevents cells from entering mitosis when DNA is damaged, providing an opportunity for repair and stopping the proliferation of damaged cells. Because the G2 checkpoint helps to maintain genomic stability, it is an important focus in understanding the molecular causes of cancer. Many different methods have been used to investigate the G2 checkpoint and uncover some of the underlying mechanisms. Because cell cycle controls are highly conserved, a remarkable synergy between the genetic power of model organisms and biochemical analyses is possible and has uncovered control mechanisms that operate in many diverse species, including humans. CDC2, the cyclin-dependent kinase that normally drives cells into mitosis, is the ultimate target of pathways that mediate rapid arrest in G2 in response to DNA damage. Additional pathways ensure that the arrest is stably maintained. When mammalian cells contain damaged DNA, the p53 tumor suppressor and the Rb family of transcriptional repressors work together to downregulate a large number of genes that encode proteins required for G2 and M. Elimination of these essential cell cycle proteins helps to keep the cells arrested in G2.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Education
  • Science
  • Telecommunications

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We can't figure out the monetization strategy.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {πŸ”}

google, scholar, cas, pubmed, article, cell, dna, biol, checkpoint, kinase, damage, nature, protein, cycle, mol, cdc, control, science, gene, genes, cells, phosphorylation, cancer, yeast, human, dev, cyclin, chem, response, mitotic, sci, mitosis, fission, nuclear, proc, natl, acad, chk, activation, usa, res, complex, stark, taylor, arrest, embo, atm, rad, cellular, nurse,

Topics {βœ’οΈ}

p130/p107/p105rb-dependent transcriptional repression dna-damage-induced cell-cycle exit p21 waf1/cip1 expression month download article/chapter gadd45-mediated growth suppression cdc2-related protein p40m015 g2-phase dna-damage checkpoint check-point signalling dna double-strand breaks intrinsic dna/chromatin binding p53 c-terminal domain rad3-rad26 complex responds dna damage-induced phosphorylation cell cycle-regulated kinase chk1-encoded protein kinase ran-independent nuclear import purified maturation-promoting factor cell cycle checkpoints s-phase feedback control site-directed cofactor recruitment kinase-inactive atr protein mre 11/rad50/nbs1 complex g1/s-regulated e2f phase-promoting factor phosphorylation van de weyer full article pdf cell cycle controls p53-regulated protein gadd45 related subjects early mitotic events multiple protein kinases lerner research institute histone h1 kinase rad checkpoint pathway cdc34-mediated degradation cdk/cyclin complexes mutated p53 gene mitotic chromosomes induced privacy choices/manage cookies dna damage checkpoint cell cycle checkpoint mo15 gene encodes sea urchin eggs cyclin-dependent kinase cell cycle arrest p130-e2f-4 complex check access dna damage occurs dna damage independently mediate rapid arrest

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Control of the G2/M transition
         description:The G2 checkpoint prevents cells from entering mitosis when DNA is damaged, providing an opportunity for repair and stopping the proliferation of damaged cells. Because the G2 checkpoint helps to maintain genomic stability, it is an important focus in understanding the molecular causes of cancer. Many different methods have been used to investigate the G2 checkpoint and uncover some of the underlying mechanisms. Because cell cycle controls are highly conserved, a remarkable synergy between the genetic power of model organisms and biochemical analyses is possible and has uncovered control mechanisms that operate in many diverse species, including humans. CDC2, the cyclin-dependent kinase that normally drives cells into mitosis, is the ultimate target of pathways that mediate rapid arrest in G2 in response to DNA damage. Additional pathways ensure that the arrest is stably maintained. When mammalian cells contain damaged DNA, the p53 tumor suppressor and the Rb family of transcriptional repressors work together to downregulate a large number of genes that encode proteins required for G2 and M. Elimination of these essential cell cycle proteins helps to keep the cells arrested in G2.
         datePublished:
         dateModified:
         pageStart:227
         pageEnd:248
         sameAs:https://doi.org/10.1385/MB:32:3:227
         keywords:
            CDC2
            cyclin
            CDK
            mitosis
            p53
            DNA damage
            Biotechnology
            Biochemistry
            general
            Cell Biology
            Protein Science
            Biological Techniques
            Human Genetics
         image:
         isPartOf:
            name:Molecular Biotechnology
            issn:
               1559-0305
               1073-6085
            volumeNumber:32
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Humana Press
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:George R. Stark
               affiliation:
                     name:The Cleveland Clinic Foundation
                     address:
                        name:Department of Molecular Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:William R. Taylor
               affiliation:
                     name:University of Toledo
                     address:
                        name:Department of Biological Sciences, University of Toledo, Toledo
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Control of the G2/M transition
      description:The G2 checkpoint prevents cells from entering mitosis when DNA is damaged, providing an opportunity for repair and stopping the proliferation of damaged cells. Because the G2 checkpoint helps to maintain genomic stability, it is an important focus in understanding the molecular causes of cancer. Many different methods have been used to investigate the G2 checkpoint and uncover some of the underlying mechanisms. Because cell cycle controls are highly conserved, a remarkable synergy between the genetic power of model organisms and biochemical analyses is possible and has uncovered control mechanisms that operate in many diverse species, including humans. CDC2, the cyclin-dependent kinase that normally drives cells into mitosis, is the ultimate target of pathways that mediate rapid arrest in G2 in response to DNA damage. Additional pathways ensure that the arrest is stably maintained. When mammalian cells contain damaged DNA, the p53 tumor suppressor and the Rb family of transcriptional repressors work together to downregulate a large number of genes that encode proteins required for G2 and M. Elimination of these essential cell cycle proteins helps to keep the cells arrested in G2.
      datePublished:
      dateModified:
      pageStart:227
      pageEnd:248
      sameAs:https://doi.org/10.1385/MB:32:3:227
      keywords:
         CDC2
         cyclin
         CDK
         mitosis
         p53
         DNA damage
         Biotechnology
         Biochemistry
         general
         Cell Biology
         Protein Science
         Biological Techniques
         Human Genetics
      image:
      isPartOf:
         name:Molecular Biotechnology
         issn:
            1559-0305
            1073-6085
         volumeNumber:32
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Humana Press
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:George R. Stark
            affiliation:
                  name:The Cleveland Clinic Foundation
                  address:
                     name:Department of Molecular Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:William R. Taylor
            affiliation:
                  name:University of Toledo
                  address:
                     name:Department of Biological Sciences, University of Toledo, Toledo
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Molecular Biotechnology
      issn:
         1559-0305
         1073-6085
      volumeNumber:32
Organization:
      name:Humana Press
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The Cleveland Clinic Foundation
      address:
         name:Department of Molecular Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland
         type:PostalAddress
      name:University of Toledo
      address:
         name:Department of Biological Sciences, University of Toledo, Toledo
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:George R. Stark
      affiliation:
            name:The Cleveland Clinic Foundation
            address:
               name:Department of Molecular Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland
               type:PostalAddress
            type:Organization
      name:William R. Taylor
      affiliation:
            name:University of Toledo
            address:
               name:Department of Biological Sciences, University of Toledo, Toledo
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Molecular Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland
      name:Department of Biological Sciences, University of Toledo, Toledo
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(508)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

5.08s.